{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:05:55Z","timestamp":1790809555474,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12023116"],"award-info":[{"award-number":["SHDC12023116"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171078"],"award-info":[{"award-number":["82171078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25J32800203"],"award-info":[{"award-number":["25J32800203"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To explore the clinical features of bilateral ocular toxocariasis (OT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this case-series, the ocular characteristics and treatments of the patients diagnosed with bilateral OT from 2015 to 2024 were reviewed and analyzed. The influences of clinical manifestations on prognosis were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ten patients aged 21\u2009\u00b1\u200915 years were included. In all the patients, the onset of the two eyes was asynchronous. The first-affected eyes (FAEs) had worse visual acuity than the second-affected eyes (SAEs) (paired t test,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.024). Peripheral granulomas were observed in 16 eyes (FAE\/SAE: 9\/7), followed by posterior granulomas in 3 eyes (all FAEs). The peripheral granulomas in FAEs were longer than those in paired SAEs (6.38\u2009\u00b1\u20091.69\u00a0mm versus 5.29\u2009\u00b1\u20091.77\u00a0mm,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.045). Cyclitic membrane, vitreous strand, epiretinal membrane, tractional retinal detachment and ciliary body detachment were observed in 10 (FAE\/SAE: 5\/5), 6 (FAE\/SAE: 3\/3), 12 (FAE\/SAE: 7\/5), 5 (FAE\/SAE: 2\/3) and 1(FAE) eye at baseline, respectively. The incidences of these lesions didn\u2019t vary greatly from baseline to the latest visits except for an increased incidence of tractional retinal detachment (25% to 60%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.016). Cataract, posterior synechia, band keratopathy and ocular hypertension occurred in 14 (FAE\/SAE: 8\/6), 9 (FAE\/SAE: 6\/3), 5 (FAE\/SAE: 3\/2) and 7 eyes (FAE\/SAE: 4\/3), respectively. Peripheral granulomas might be correlated with poor visual recovery in this series (Stepwise linear regression,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Bilateral OT cases tended to have an asynchronous onset and asymmetric severity between the two eyes. Such feature could help to maintain the diagnosis of OT and prompt further test of anti-\n                      <jats:italic>T. canis<\/jats:italic>\n                      antibody for confirmation despite bilateral involvement.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-026-00618-6","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:34:47Z","timestamp":1783438487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ophthalmic manifestation of bilateral ocular toxocariasis: a case-series"],"prefix":"10.1186","volume":"16","author":[{"given":"Junxiang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-8980","authenticated-orcid":false,"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","unstructured":"Shields JA (1984) Ocular toxocariasis. a review. Surv Ophthalmol 28(5):361\u2013381. https:\/\/doi.org\/10.1016\/0039-6257(84)90242-x","DOI":"10.1016\/0039-6257(84)90242-x"},{"key":"618_CR2","doi-asserted-by":"publisher","unstructured":"Woodhall D, Starr MC, Montgomery SP, Jones JL, Lum F, Read RW, Moorthy RS (2012) Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology 119(6):1211\u20131217. https:\/\/doi.org\/10.1016\/j.ophtha.12.013","DOI":"10.1016\/j.ophtha.12.013"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajo.2016.03.050","volume":"166","author":"R Despreaux","year":"2016","unstructured":"Despreaux R, Fardeau C, Touhami S, Brasnu E, Champion E, Paris L, Touitou V, Bodaghi B, Lehoang P (2016) Ocular toxocariasis: clinical features and long-term visual outcomes in adult patients. Am J Ophthalmol 166:162\u2013168. https:\/\/doi.org\/10.1016\/j.ajo.2016.03.050","journal-title":"AM J OPHTHALMOL"},{"key":"618_CR4","doi-asserted-by":"publisher","unstructured":"Zhou M, Chang Q, Gonzales JA, Chen Q, Zhang Y, Huang X, Xu G, Wang W, Jiang R (2012) Clinical characteristics of ocular toxocariasis in Eastern China. Graefes Arch Clin Exp Ophthalmol 250(9):1373\u20131378. https:\/\/doi.org\/10.1007\/s00417-012--2","DOI":"10.1007\/s00417-012--2"},{"key":"618_CR5","doi-asserted-by":"publisher","unstructured":"Stewart JM, Cubillan LD, Cunningham EJ (2005) Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina 25(8):1005\u20131013. https:\/\/doi.org\/10.1097\/00006982-200512000-00009","DOI":"10.1097\/00006982-200512000-00009"},{"key":"618_CR6","doi-asserted-by":"publisher","unstructured":"Good B, Holland CV, Taylor MR, Larragy J, Moriarty P, O\u2019Regan M (2004) Ocular toxocariasis in schoolchildren. Clin Infect Dis 39(2):173\u2013178. https:\/\/doi.org\/10.1086\/421492","DOI":"10.1086\/421492"},{"key":"618_CR7","doi-asserted-by":"publisher","unstructured":"Rostami A, Ma G, Wang T, Koehler AV, Hofmann A, Chang B, Macpherson CN, Gasser RB (2019) Human toxocariasis \u2013 a look at a neglected disease through an epidemiological prism. Infect Genet Evol 74:104002. https:\/\/doi.org\/10.1016\/j.meegid.104002","DOI":"10.1016\/j.meegid.104002"},{"key":"618_CR8","doi-asserted-by":"publisher","unstructured":"Ma G, Holland CV, Wang T, Hofmann A, Fan CK, Maizels RM, Hotez PJ, Gasser RB (2018) Human toxocariasis. Lancet Infect Dis 18(1):e14\u2013e24. https:\/\/doi.org\/10.1016\/S1473-3099(17)30331-6","DOI":"10.1016\/S1473-3099(17)30331-6"},{"issue":"4","key":"618_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1076\/ocii.11.4.269.18266","volume":"11","author":"K Yokoi","year":"2003","unstructured":"Yokoi K, Goto H, Sakai J, Usui M (2003) Clinical features of ocular toxocariasis in Japan. Ocul Immunol Inflamm 11(4):269\u2013275. https:\/\/doi.org\/10.1076\/ocii.11.4.269.18266","journal-title":"OCUL IMMUNOL INFLAMM"},{"issue":"2","key":"618_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1079\/JOH200175","volume":"75","author":"MR Taylor","year":"2001","unstructured":"Taylor MR (2001) The epidemiology of ocular toxocariasis. J Helminthol 75(2):109\u2013118","journal-title":"J HELMINTHOL"},{"issue":"5","key":"618_CR11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/bjophthalmol-2017-310583","volume":"102","author":"Q Chen","year":"2018","unstructured":"Chen Q, Gu J, Jiang R, Zhou M, Chang Q (2018) Role of ultrasound biomicroscopy in diagnosis of ocular toxocariasis. Br J Ophthalmol 102(5):642\u2013646. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310583","journal-title":"BRIT J OPHTHALMOL"},{"issue":"3","key":"618_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.oret.2023.10.002","volume":"8","author":"J Gu","year":"2024","unstructured":"Gu J, Chen Q, Zhang P, Zhang T, Zhou X, Zhang K, Jiang T, Liu S, Chen W, Zhou M, Jiang R, Huang X, Xu G, Chang Q (2024) Characteristics of vitreoretinal lymphoma in B-scan ultrasonography: a case-control study. Ophthalmol Retina 8(3):264\u2013269. https:\/\/doi.org\/10.1016\/j.oret.2023.10.002","journal-title":"OPHTHALMOL RETINA"},{"key":"618_CR13","doi-asserted-by":"publisher","unstructured":"Wang ZJ, Zhou M, Cao WJ, Ji J, Bi YW, Huang X, Xu GZ (2016) Evaluation of the Goldmann\u2013Witmer coefficient in the immunological diagnosis of ocular toxocariasis. Acta Trop 158:20\u201323. https:\/\/doi.org\/10.1016\/j.actatropica.2016.02.013","DOI":"10.1016\/j.actatropica.2016.02.013"},{"issue":"10","key":"618_CR14","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1038\/s41433-020-01332-w","volume":"35","author":"S Li","year":"2021","unstructured":"Li S, Sun L, Liu C, Wang W, Huang S, Zhang T, Chen C, Wang Z, Cao L, Luo X, Yu B, Ding X (2021) Clinical features of ocular toxocariasis: a comparison between ultra-wide-field and conventional camera imaging. Eye 35(10):2855\u20132863. https:\/\/doi.org\/10.1038\/s41433-020-01332-w","journal-title":"EYE"},{"key":"618_CR15","doi-asserted-by":"publisher","unstructured":"Lee TH, Ji YS, Lee SH (2015) ELISA-confirmed bilateral ocular toxocariasis with different features. Optom Vis Sci 92(8):e176\u2013e179. https:\/\/doi.org\/10.1097\/OPX.0000000000000665","DOI":"10.1097\/OPX.0000000000000665"},{"key":"618_CR16","doi-asserted-by":"publisher","unstructured":"Garg RK, Garg P, Paliwal VK, Pandey S (2024) Vision loss in neurocysticercosis: a systematic review of case reports and series. J Clin Neurol 21(2):137\u2013145. https:\/\/doi.org\/10.3988\/jcn.0565","DOI":"10.3988\/jcn.0565"},{"key":"618_CR17","doi-asserted-by":"publisher","unstructured":"Kazacos KR, Jelicks LA, Tanowitz HB (2013) Baylisascaris larva migrans. Handb Clin Neurol 114:251\u2013262. https:\/\/doi.org\/10.1016\/B978-0-444-53490-3.00020-0","DOI":"10.1016\/B978-0-444-53490-3.00020-0"},{"key":"618_CR18","doi-asserted-by":"publisher","unstructured":"Badri M, Eslahi AV, Olfatifar M, Dalvand S, Houshmand E, Abdoli A, Majidiani H, Eslami A, Zibaei M, Johkool MG, Taghipour A, Hashemipour S (2021) Keys to unlock the enigma of ocular toxocariasis: a systematic review and meta-analysis. Ocul Immunol Inflamm 29(7\u20138):1265\u20131276. https:\/\/doi.org\/10.1080\/09273948.1875007","DOI":"10.1080\/09273948.1875007"},{"key":"618_CR19","doi-asserted-by":"publisher","unstructured":"Babu S, Blauvelt CP, Kumaraswami V, Nutman TB (2005) Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J Immunol 175(2):1170\u20131176. https:\/\/doi.org\/10.4049\/jimmunol.175.2.1170","DOI":"10.4049\/jimmunol.175.2.1170"},{"issue":"3","key":"618_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2567.2004.02083.x","volume":"114","author":"KP Singh","year":"2005","unstructured":"Singh KP, Gerard HC, Hudson AP, Reddy TR, Boros DL (2005) Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology 114(3):410\u2013417. https:\/\/doi.org\/10.1111\/j.1365-2567.2004.02083.x","journal-title":"Immunology"},{"key":"618_CR21","doi-asserted-by":"publisher","unstructured":"Zhang T, Guo D, Xu G, Jiang R (2020) Ocular toxocariasis: long-term follow-up and prognosis of patients following vitrectomy. Ocul Immunol Inflamm 28(3):517\u2013523. https:\/\/doi.org\/10.1080\/09273948.2019.1597897","DOI":"10.1080\/09273948.2019.1597897"},{"issue":"8","key":"618_CR22","doi-asserted-by":"publisher","first-page":"e202904","DOI":"10.1371\/journal.pone.0202904","volume":"13","author":"JW Kwon","year":"2018","unstructured":"Kwon JW, Lee SY, Jee D, Cho YK (2018) Prognosis for ocular toxocariasis according to granuloma location. PLoS ONE 13(8):e202904. https:\/\/doi.org\/10.1371\/journal.pone.0202904","journal-title":"PLoS ONE"},{"key":"618_CR23","doi-asserted-by":"publisher","unstructured":"Yiu MK, Ho M, Ho ACH, Chan WKY, Yung W, Yip WWK, Young AL (2024) Paediatric uveitis \u2013 the uniqueness in clinical presentation and the efficacy of biologics treatment. J Ophthalmic Inflamm 14(1):34. https:\/\/doi.org\/10.1186\/s12348-024-00415-z","DOI":"10.1186\/s12348-024-00415-z"},{"issue":"1","key":"618_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12348-025-00458-w","volume":"15","author":"JM Gunzinger","year":"2025","unstructured":"Gunzinger JM, Palmer Sarott S, Meier F, B\u00f6ni C, Kitay A, Simonsz-T\u00f3th B, Gerth-Kahlert C (2025) Treatment outcomes of a Swiss non-infectious paediatric uveitis cohort: retrospective study over ten years. J Ophthalmic Inflamm 15(1):43. https:\/\/doi.org\/10.1186\/s12348-025-00458-w","journal-title":"J OPHTHALMIC INFLAMM"},{"key":"618_CR25","doi-asserted-by":"publisher","unstructured":"Alshehri AF, Alhazzani R, Almazrou AA, Almutairi FM, Barnawi AB, Aldail AA, Alfarhan YI, Alshammari KG, Alotaibi BM, Alanazi BK, Alanazi AS (2026) Initiation and continuation of adalimumab with methotrexate for juvenile idiopathic arthritis-associated uveitis: systematic review and meta-analysis of randomized controlled trials. Ocul Immunol Inflamm 34(4):777\u2013784. https:\/\/doi.org\/10.1080\/09273948.2646604","DOI":"10.1080\/09273948.2646604"},{"issue":"3","key":"618_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10067-019-04875-w","volume":"39","author":"E Miserocchi","year":"2020","unstructured":"Miserocchi E, Giuffr\u00e8 C, Cornalba M, Pontikaki I, Cimaz R (2020) JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis. Clin Rheumatol 39(3):847\u2013851. https:\/\/doi.org\/10.1007\/s10067-019-04875-w","journal-title":"CLIN RHEUMATOL"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-026-00618-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:33:35Z","timestamp":1790807615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-026-00618-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1186\/s12348-026-00618-6","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of Eye & ENT Hospital of Fudan University (Approval No. 2020119-1). Written informed consent was waived due to the retrospective design of this study and no invasive examination involved.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"58"}}